BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33899766)

  • 1. Correlation of FISH and PRAME Immunohistochemistry in Ambiguous Superficial Cutaneous Melanocytic Proliferations.
    Harvey NT; Peverall J; Acott N; Mesbah Ardakani N; Leecy TN; Iacobelli J; McCallum D; Van Vliet C; Wood BA
    Am J Dermatopathol; 2021 Dec; 43(12):913-920. PubMed ID: 33899766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Busam KJ
    Am J Surg Pathol; 2020 Jul; 44(7):893-900. PubMed ID: 32317605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations.
    Casillas AC; Muhlbauer A; Barragan VA; Jefferson I; Speiser JJ
    Am J Dermatopathol; 2024 Mar; 46(3):137-146. PubMed ID: 38354382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors.
    Alomari AK; Tharp AW; Umphress B; Kowal RP
    J Cutan Pathol; 2021 Sep; 48(9):1115-1123. PubMed ID: 33660310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of PRAME in distinguishing proliferative nodules from melanoma in giant congenital melanocytic nevi.
    Gill P; Prieto VG; Austin MT; Giubellino A; Torres-Cabala CA
    J Cutan Pathol; 2021 Nov; 48(11):1410-1415. PubMed ID: 34164835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferentially expressed Antigen in MElanoma immunohistochemistry as an adjunct for evaluating ambiguous melanocytic proliferation.
    Fattori A; de la Fouchardière A; Cribier B; Mitcov M
    Hum Pathol; 2022 Mar; 121():19-28. PubMed ID: 34990622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRAME Immunohistochemistry for Distinguishing Vulvar and Vaginal Melanoma From Benign Melanocytic Nevi.
    Martin SD; Martin KC; Gilks CB; Crawford RI; Hoang LN
    Int J Gynecol Pathol; 2024 Jul; 43(4):389-396. PubMed ID: 38085951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions.
    Lezcano C; Jungbluth AA; Busam KJ
    Surg Pathol Clin; 2021 Jun; 14(2):165-175. PubMed ID: 34023098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME Expression Correlates With Genomic Aberration and Malignant Diagnosis of Spitzoid Melanocytic Neoplasms.
    Gerami P; Benton S; Zhao J; Zhang B; Lampley N; Roth A; Boutko A; Olivares S; Busam KJ
    Am J Dermatopathol; 2022 Aug; 44(8):575-580. PubMed ID: 35503885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
    LeBlanc RE; Miller DM; Zegans ME
    J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfalls of PRAME Immunohistochemistry in a Large Series of Melanocytic and Nonmelanocytic Lesions With Literature Review.
    Turner N; Ko CJ; McNiff JM; Galan A
    Am J Dermatopathol; 2024 Jan; 46(1):21-30. PubMed ID: 37982498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
    Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
    J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.
    Huang YY; Hrycaj SM; Chan MP; Stagner AM; Patel RM; Bresler SC
    Am J Dermatopathol; 2022 Oct; 44(10):734-740. PubMed ID: 35475786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRAME Immunohistochemical Expression and TERT Promoter Mutational Analysis as Ancillary Diagnostic Tools for Differentiating Proliferative Nodules From Melanoma Arising in Congenital Nevi.
    Boutko A; Hagstrom M; Lampley N; Roth A; Olivares S; Dhillon S; Fumero-Velázquez M; Benton S; Zhao J; Zhang B; Dittmann D; Asadbeigi S; Busam KJ; Gerami P
    Am J Dermatopathol; 2023 Jul; 45(7):437-447. PubMed ID: 37338065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    Bahmad HF; Oh KS; Alexis J
    J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic test accuracy meta-analysis of PRAME in distinguishing primary cutaneous melanomas from benign melanocytic lesions.
    Kunc M; Żemierowska N; Skowronek F; Biernat W
    Histopathology; 2023 Jul; 83(1):3-14. PubMed ID: 36942814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of immunohistochemical staining of PRAME in differential diagnosis between melanoma and melanocytic nevus].
    Du J; Yu WJ; Guo RP; Su J
    Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):621-626. PubMed ID: 35785832
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of S100A8 and PRAME as biomarkers for distinguishing melanoma from melanocytic naevus: a case-control analysis.
    Hai J; Meyer SN; Wong SL; Li Y; Simmons E; Miglioretti D; Fung MA; Kiuru M
    Clin Exp Dermatol; 2024 May; 49(6):584-590. PubMed ID: 38306117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.